Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
European Journal of Clinical Investigation
|
December 22, 2006
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells
A W Hauswirth, S Florian, D Printz, et al.
Prostate Cancer and Prostatic Diseases
|
January 11, 2012
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies
M Braun, D Goltz, D Adler, et al.
Der Urologe. Ausg. A
|
August 19, 2007
[The interdisciplinary approach to improve treatment quality of prostate cancer. Optimized nerve sparing in radical prostatectomy]
K-D Sievert, A G Anastasiadis, J Hennenlotter, et al.
Annals of Hematology
|
November 19, 2013
Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis
Sigrid Machherndl-Spandl, W Sega, H Bösmüller, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 23, 2014
Predictors of clinical effectiveness of Hymenoptera venom immunotherapy
F Ruëff, B Vos, J Oude Elberink, et al.
Leukemia
|
July 16, 2016
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis
M Jawhar, J Schwaab, D Hausmann, et al.
Leukemia
|
January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M Jawhar, J Schwaab, S Schnittger, et al.
Leukemia
|
October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis
M Jawhar, J Schwaab, S Schnittger, et al.
Leukemia
|
January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disorders
P Valent, K Sotlar, K Blatt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activation
P Valent, C Akin, K Hartmann, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
European Journal of Clinical Investigation
|
December 22, 2006
Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells
A W Hauswirth, S Florian, D Printz, et al.
Prostate Cancer and Prostatic Diseases
|
January 11, 2012
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer--a comparative study of two monoclonal antibodies
M Braun, D Goltz, D Adler, et al.
Der Urologe. Ausg. A
|
August 19, 2007
[The interdisciplinary approach to improve treatment quality of prostate cancer. Optimized nerve sparing in radical prostatectomy]
K-D Sievert, A G Anastasiadis, J Hennenlotter, et al.
Annals of Hematology
|
November 19, 2013
Prognostic impact of blast cell counts in dysplastic bone marrow disorders (MDS and CMML I) with concomitant fibrosis
Sigrid Machherndl-Spandl, W Sega, H Bösmüller, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
January 23, 2014
Predictors of clinical effectiveness of Hymenoptera venom immunotherapy
F Ruëff, B Vos, J Oude Elberink, et al.
Leukemia
|
July 16, 2016
Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis
M Jawhar, J Schwaab, D Hausmann, et al.
Leukemia
|
January 9, 2015
Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event
M Jawhar, J Schwaab, S Schnittger, et al.
Leukemia
|
October 15, 2015
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis
M Jawhar, J Schwaab, S Schnittger, et al.
Leukemia
|
January 17, 2017
Proposed diagnostic criteria and classification of basophilic leukemias and related disorders
P Valent, K Sotlar, K Blatt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Midostaurin: a magic bullet that blocks mast cell expansion and activation
P Valent, C Akin, K Hartmann, et al.
Page
of 6